These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15839358)

  • 41. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
    Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
    Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K; Font RL
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?
    Vaisfeld A; Calicchia M; Pomponi MG; Lucci-Cordisco E; Reggiani-Bonetti L; Genuardi M
    Fam Cancer; 2019 Oct; 18(4):421-427. PubMed ID: 31292797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Muir-Torre syndrome].
    Jonas J; Kruse R; Bähr R
    Chirurg; 2002 Apr; 73(4):366-9. PubMed ID: 12063922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics.
    Orta L; Klimstra DS; Qin J; Mecca P; Tang LH; Busam KJ; Shia J
    Am J Surg Pathol; 2009 Jun; 33(6):934-44. PubMed ID: 19342947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solitary subungual keratoacanthoma arising in an MSH2 germline mutation carrier: confirmation of a relationship by immunohistochemical analysis.
    Stoebner PE; Fabre C; Delfour C; Joujoux JM; Roger P; Dandurand M; Meunier L
    Dermatology; 2009; 219(2):174-8. PubMed ID: 19602866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
    Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
    Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The frequency of Muir-Torre syndrome among Lynch syndrome families.
    South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
    J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemistry, Molecular Biology, and Clinical Scoring for the Detection of Muir-Torre Syndrome in Cutaneous Sebaceous Tumors: Which Strategy?
    Sinson H; Karayan-Tapon L; Godet J; Rivet P; Alleyrat C; Battistella M; Pierron H; Morel F; Lecron JC; Favot L; Frouin E
    Dermatology; 2023; 239(6):889-897. PubMed ID: 37717564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genitourinary tumors in men with the Muir-Torre syndrome.
    Davis DA; Cohen PR
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):909-12. PubMed ID: 7593809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
    Cook S; Pethick J; Kibbi N; Hollestein L; Lavelle K; de Vere Hunt I; Turnbull C; Rous B; Husain A; Burn J; Lüchtenborg M; Santaniello F; McRonald F; Hardy S; Linos E; Venables Z; Rajan N
    J Am Acad Dermatol; 2023 Dec; 89(6):1129-1135. PubMed ID: 37031776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
    Kim RH; Nagler AR; Meehan SA
    J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
    [No Abstract]   [Full Text] [Related]  

  • 54. Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Thomas CS; Heckman MG; Krishna M; DiCaudo DJ; Bridges AG; Hunt KS; Rumilla KM; Cappel MA
    J Genet Couns; 2013 Jun; 22(3):393-405. PubMed ID: 23212176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination.
    Yanaba K; Nakagawa H; Takeda Y; Koyama N; Sugano K
    Br J Dermatol; 2008 Jan; 158(1):150-6. PubMed ID: 17941949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.
    Goldberg M; Rummelt C; Foja S; Holbach LM; Ballhausen WG
    Hum Mutat; 2006 Feb; 27(2):155-62. PubMed ID: 16395674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].
    Demolin G; Romain M; Münschke A; Vandingenen T; Blaude MA; Van Craynest MP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):767-74. PubMed ID: 26321614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of universal immunohistochemical screening of sebaceous neoplasms in a service setting.
    Schon K; Rytina E; Drummond J; Simmonds J; Abbs S; Sandford R; Tischkowitz M
    Clin Exp Dermatol; 2018 Jun; 43(4):410-415. PubMed ID: 29333623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.
    Cohen PR; Kohn SR; Kurzrock R
    Am J Med; 1991 May; 90(5):606-13. PubMed ID: 2029018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
    Fernandez-Flores A
    Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.